Search
Search
About
Log in
Join
Experiences with
Hepatitis E
Posts
Communities
1,452 public posts
Filter results
Central Appalachian Jump in Hep C Linked to Opioid Use
An upswing in opioid dependency and in the rate of people reporting injection drug use in four central Appalachian states has occurred in tandem with a rising hepatitis C virus (HCV) incidence, MedPage Today reports. Centers for Disease Control and Prevention (CDC) officials partnered with the health
An upswing in opioid dependency and in the rate of people reporting injection drug use in four central Appalachian states has occurred in tandem with a rising hepatitis C virus (HCV) incidence, MedPage Today reports. Centers for Disease Control and Prevention (CDC) officials partnered with the health
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Best supplement for pregnancy
Hi all just wanted others opinions on which of the supplements I've found would be the better ones too take. I've recently suffered an early loss in pregnancy so I'm not pregnant yet but want too get my levels up for when we do try again. I have pcos and very reduced fertility have appointment with gynaecologist
Hi all just wanted others opinions on which of the supplements I've found would be the better ones too take. I've recently suffered an early loss in pregnancy so I'm not pregnant yet but want too get my levels up for when we do try again. I have pcos and very reduced fertility have appointment with gynaecologist
nettiboo1982
in
Thyroid UK
9 years ago
Building Local Health Department Capacity to Support HCV Screening and Linkage to CareThe National Association of County and NACCHO
Building Local Health Department Capacity to Support HCV Screening and Linkage to Care The National Association of County and City Health Officials (NACCHO) is pleased to offer a funding opportunity for a consultant to assist in supporting and promoting the local health department role in hepatitis
Building Local Health Department Capacity to Support HCV Screening and Linkage to Care The National Association of County and City Health Officials (NACCHO) is pleased to offer a funding opportunity for a consultant to assist in supporting and promoting the local health department role in hepatitis
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Brain, cardiac death allografts did not increase HCC recurrence
Researchers, including Kristopher P. Croome, MD, MS, department of transplantation, Mayo Clinic, Jacksonville, analyzed data from 1,876 patients who underwent donation after brain death (DBD) and donation after cardiac death (DCD) at the Mayo Clinic between 2003 and 2012. Liver transplantation for hepatocellular
Researchers, including Kristopher P. Croome, MD, MS, department of transplantation, Mayo Clinic, Jacksonville, analyzed data from 1,876 patients who underwent donation after brain death (DBD) and donation after cardiac death (DCD) at the Mayo Clinic between 2003 and 2012. Liver transplantation for hepatocellular
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Foundation aims to assist HCV patients with therapy costs
The foundation, a non-profit whose goal is to provide financial assistance for uninsured Americans, will provide copayment assistance up to $15,000 for HCV therapy to eligible patients who are insured and have annual household incomes up to 500% of the federal poverty level, according to the release.
The foundation, a non-profit whose goal is to provide financial assistance for uninsured Americans, will provide copayment assistance up to $15,000 for HCV therapy to eligible patients who are insured and have annual household incomes up to 500% of the federal poverty level, according to the release.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
People Tend to Seek HIV Prevention and Testing Info at Week’s Outset
Individuals are more likely to seek out HIV prevention and testing information at the beginning of the week, and are more inclined to engage in risky sexual behaviors over the weekend. Additionally, HIV-positive people have a slightly lower rate of antiretroviral adherence during weekends. Publishing
Individuals are more likely to seek out HIV prevention and testing information at the beginning of the week, and are more inclined to engage in risky sexual behaviors over the weekend. Additionally, HIV-positive people have a slightly lower rate of antiretroviral adherence during weekends. Publishing
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
PrEP-Delivering Subdermal Implant Shows Promise in Animal Study
A subdermal implant that delivers the HIV antiretroviral tenofovir alafenamide (TAF) has shown promise as an alternative to daily pre-exposure prophylaxis (PrEP) in an animal study. Publishing their findings in Antimicrobial Agents and Chemotherapy, researchers implanted the matchstick-size device in
A subdermal implant that delivers the HIV antiretroviral tenofovir alafenamide (TAF) has shown promise as an alternative to daily pre-exposure prophylaxis (PrEP) in an animal study. Publishing their findings in Antimicrobial Agents and Chemotherapy, researchers implanted the matchstick-size device in
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Backlash to New York City’s Fear-Based HIV Prevention Campaign
The New York City Department of Health and Mental Hygiene’s recent fear-based HIV prevention campaign may have led to unintended consequences by stigmatizing young black and Latino men who have sex with men (MSM). Publishing their findings in Health Affairs, researchers analyzed the 2010 “It’s Never
The New York City Department of Health and Mental Hygiene’s recent fear-based HIV prevention campaign may have led to unintended consequences by stigmatizing young black and Latino men who have sex with men (MSM). Publishing their findings in Health Affairs, researchers analyzed the 2010 “It’s Never
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Newer Non-Nuke HIV Meds May Allow for Lower Adherence
Newer non-nucleoside transcriptase inhibitor (NNRTI, or non-nuke)–based antiretroviral (ARV) regimens may keep HIV viral loads suppressed when adherence levels are as low as 85 percent, aidsmap reports. Publishing their findings in the Journal of Acquired Immune Deficiency Syndromes, researchers from
Newer non-nucleoside transcriptase inhibitor (NNRTI, or non-nuke)–based antiretroviral (ARV) regimens may keep HIV viral loads suppressed when adherence levels are as low as 85 percent, aidsmap reports. Publishing their findings in the Journal of Acquired Immune Deficiency Syndromes, researchers from
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Hepatits B
before my viral load 18,000 after ETV treatment my viral load undetectable dr advice me you take ETV life time. life time but why?? when my all serology report negative i am only HBS antigen carrier do you agree hepatitis b immune control phase patient will lead to immune escape phase Or HBS antigen
before my viral load 18,000 after ETV treatment my viral load undetectable dr advice me you take ETV life time. life time but why?? when my all serology report negative i am only HBS antigen carrier do you agree hepatitis b immune control phase patient will lead to immune escape phase Or HBS antigen
asifkhaskheli
in
British Liver Trust
9 years ago
FDA Grants Priority Review for AbbVie's Hepatitis C Treatment
AbbVie has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) and granted priority review for the company's, all-oral, interferon-free, two direct-acting antiviral treatment of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with ribavirin (RBV). The
AbbVie has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) and granted priority review for the company's, all-oral, interferon-free, two direct-acting antiviral treatment of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with ribavirin (RBV). The
mwright
in
HFI Connect - Hepatitis
9 years ago
Hepatitis C in Japanby Alan Franciscus
This article which originally appeared in the HCV Advocate, discusses hepatitis C in Japan. Alan FranciscusOf all the industrialized countries of the world, Japan has the highest rate of hepatitis C (HCV). It also has one of the oldest and most varied histories of hepatitis C in the world among the
This article which originally appeared in the HCV Advocate, discusses hepatitis C in Japan. Alan FranciscusOf all the industrialized countries of the world, Japan has the highest rate of hepatitis C (HCV). It also has one of the oldest and most varied histories of hepatitis C in the world among the
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Hepatitis C: Giving a Liver, Getting a Liverby Lucinda Porter
This article from the HCV Advocate discusses issues relating to liver transplantation and organ donation. Years of living with chronic hepatitis C virus infection (HCV) destroyed my friend Rick’s liver. Last year, a liver transplant saved his life. A motor vehicle accident killed a 19-year-old man
This article from the HCV Advocate discusses issues relating to liver transplantation and organ donation. Years of living with chronic hepatitis C virus infection (HCV) destroyed my friend Rick’s liver. Last year, a liver transplant saved his life. A motor vehicle accident killed a 19-year-old man
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Harvoni Beats Hep C Among Those With Advanced Liver Disease
Gilead Sciences’ Harvoni (ledipasvir/sofosbuvir) and ribavirin cures hepatitis C virus (HCV) at mostly high rates among those with decompensated cirrhosis or who have had recurrent hep C after a liver transplant, MedPage Today reports. Researchers in the SOLAR-2 trial gave 12 or 24 weeks of the regimen
Gilead Sciences’ Harvoni (ledipasvir/sofosbuvir) and ribavirin cures hepatitis C virus (HCV) at mostly high rates among those with decompensated cirrhosis or who have had recurrent hep C after a liver transplant, MedPage Today reports. Researchers in the SOLAR-2 trial gave 12 or 24 weeks of the regimen
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Joint Pain Flares Among People With HIV, Hepatitis C or Both
People with HIV or hepatitis C virus (HCV), or who are coinfected with both viruses, report high levels of joint pain, aidsmap reports. Publishing their findings in BMC Musculoskeletal Disorders, researchers conducted a cross-sectional study in which they interviewed 202 participants about joint pain
People with HIV or hepatitis C virus (HCV), or who are coinfected with both viruses, report high levels of joint pain, aidsmap reports. Publishing their findings in BMC Musculoskeletal Disorders, researchers conducted a cross-sectional study in which they interviewed 202 participants about joint pain
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Daclatasvir and Sovaldi Cure High Rates of Genotype 1 of Hep C
A recent trial suggests that Bristol-Myers Squibb’s daclatasvir plus Gilead Sciences’ Sovaldi (sofosbuvir), with or without ribavirin, cures high rates of people with genotype 1 of hepatitis C virus (HCV), including those with cirrhosis. Preliminary results from the trial were reported at the 50th International
A recent trial suggests that Bristol-Myers Squibb’s daclatasvir plus Gilead Sciences’ Sovaldi (sofosbuvir), with or without ribavirin, cures high rates of people with genotype 1 of hepatitis C virus (HCV), including those with cirrhosis. Preliminary results from the trial were reported at the 50th International
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Could a Cancer Drug Cure Hepatitis B?
A cancer drug has shown promise as a potential cure for hepatitis B virus (HBV). Publishing their findings in the Proceedings of the National Academy of Sciences, Australian researchers studied the effects of a combination treatment on hep B-infected liver cells, using the antiviral drug entecavir and
A cancer drug has shown promise as a potential cure for hepatitis B virus (HBV). Publishing their findings in the Proceedings of the National Academy of Sciences, Australian researchers studied the effects of a combination treatment on hep B-infected liver cells, using the antiviral drug entecavir and
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Harvoni Beats Hep C Among Those With Advanced Liver Disease
Gilead Sciences’ Harvoni (ledipasvir/sofosbuvir) and ribavirin cures hepatitis C virus (HCV) at mostly high rates among those with decompensated cirrhosis or who have had recurrent hep C after a liver transplant, MedPage Today reports. Researchers in the SOLAR-2 trial gave 12 or 24 weeks of the regimen
Gilead Sciences’ Harvoni (ledipasvir/sofosbuvir) and ribavirin cures hepatitis C virus (HCV) at mostly high rates among those with decompensated cirrhosis or who have had recurrent hep C after a liver transplant, MedPage Today reports. Researchers in the SOLAR-2 trial gave 12 or 24 weeks of the regimen
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
How many times have you told your story?
You’ve told your hepatitis story a million times. Now, tell it to those who can do something to help cure it. Act now by taking the HepPRN survey. http://www.hepatitisfoundation.org/RESEARCH/Patient_Registry.html You have you told your story in support groups, to doctors, to family and others.
You’ve told your hepatitis story a million times. Now, tell it to those who can do something to help cure it. Act now by taking the HepPRN survey. http://www.hepatitisfoundation.org/RESEARCH/Patient_Registry.html You have you told your story in support groups, to doctors, to family and others.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
May 2015 Is National Hepatitis Awareness Month
In observance of National Hepatitis Awareness Month, which takes place every May, the U.S. government is once again working to increase knowledge of the hepatitis C virus (HCV) and hepatitis B virus (HBV), which together affect between 3.5 million and 5.3 million Americans, according to AIDS.gov. Continue
In observance of National Hepatitis Awareness Month, which takes place every May, the U.S. government is once again working to increase knowledge of the hepatitis C virus (HCV) and hepatitis B virus (HBV), which together affect between 3.5 million and 5.3 million Americans, according to AIDS.gov. Continue
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
1
...
59
60
61
...
73
Next page
20
30
40
50
60
70
Filter results
Clear filters
Posted in
All communities
British Liver Trust
357 results
HFI Connect - Hepatitis
225 results
Thyroid UK
97 results
View top 10 communities
Sort by
Most Relevant
Newest